Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: An overview of bovine respiratory disease PART 06: Market landscape • Market overview • Five forces analysis PART 07: Market segmentation by product category • Antibiotics • Vaccines • Others PART 08: Geographical segmentation • BRD vaccine market in Americas • BRD treatment market in EMEA • BRD treatment market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 11: Market trends • Growing focus on the development of combination drugs • Increase in preventive measures • Advancements in technology PART 12: Vendor landscape • Competitive scenario PART 13: Key vendor analysis • Bayer HealthCare • Boehringer Ingelheim • Elanco • Merck • Zoetis • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global BRD treatment market Exhibit 02: Global BRD treatment market 2016-2021 ($ millions) Exhibit 03: Opportunity analysis in global BRD treatment market Exhibit 04: Five forces analysis Exhibit 05: Market segmentation by product category 2016 Exhibit 06: Important antibiotics prescribed for treatment for BRD Exhibit 07: Global antibiotics segment in BRD treatment market 2016-2021 ($ millions) Exhibit 08: Important vaccines for prevention of BRD Exhibit 09: Global vaccines segment in BRD treatment market 2016-2021 ($ millions) Exhibit 10: Global others segment in BRD treatment market 2016-2021 ($ millions) Exhibit 11: Segmentation of global BRD treatment market based on geography 2016 and 2021 Exhibit 12: BRD treatment market revenue by geography 2016-2021 ($ millions) Exhibit 13: Market scenario in Americas Exhibit 14: BRD treatment market in Americas 2016-2021 ($ millions) Exhibit 15: Market scenario in EMEA Exhibit 16: BRD treatment market in EMEA 2016-2021 ($ millions) Exhibit 17: Market scenario in APAC Exhibit 18: BRD treatment market in APAC 2016-2021 ($ millions) Exhibit 19: Impact of drivers Exhibit 20: Impact of challenges Exhibit 21: Competitive structure analysis of global BRD treatment market 2016 Exhibit 22: Competitive analysis of global BRD treatment market Exhibit 23: Strategic success factors of companies in global BRD treatment market Exhibit 24: Bayer HealthCare: Key highlights Exhibit 25: Bayer HealthCare: Strength assessment Exhibit 26: Bayer HealthCare: Strategy assessment Exhibit 27: Bayer HealthCare: Opportunity assessment Exhibit 28: Boehringer Ingelheim: Key highlights Exhibit 29: Boehringer Ingelheim: Strength assessment Exhibit 30: Boehringer Ingelheim: Strategy assessment Exhibit 31: Boehringer Ingelheim: Opportunity assessment Exhibit 32: Elanco: Key highlights Exhibit 33: Elanco: Strength assessment Exhibit 34: Elanco: Strategy assessment Exhibit 35: Elanco: Opportunity assessment Exhibit 36: Merck: Key highlights Exhibit 37: Merck: Strength assessment Exhibit 38: Merck: Strategy assessment Exhibit 39: Merck: Opportunity assessment Exhibit 40: Zoetis: Key highlights Exhibit 41: Zoetis: Strength assessment Exhibit 42: Zoetis: Strategy assessment Exhibit 43: Zoetis: Opportunity assessment

Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, Zoetis, Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Norbrook Laboratories, and Plumbline Life Sciences.